Skip to content

Clinical trials

Phase 3 Diabetes Complications trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Complications Phase: Phase 3 Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20073
20111
20121
20141
20181
20191
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Terminated3
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Florida Atlantic University2
Alessandro Doria1
Centro Universitario de Tonalá1
Eurofarma Laboratorios S.A.1
Merck Sharp & Dohme LLC1
Northwestern University1
University of Michigan1
Wyeth is now a wholly owned subsidiary of Pfizer1
Xequel Bio, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Complications10
Diabetes Mellitus5
Diabetic Foot3
Diabetes Mellitus, Type 22
Osteomyelitis2
Bacterial Infections1
Cellulitis1
Coronary Artery Disease1
Diabetes Mellitus, Type 11
Diabetic Nephropathies1

Trials

Showing 26 to 10 of 10. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.